Clinical Trial Update: Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intratumoral L19IL2 or L19TNF or L19IL2/L19TNF in combination with pembrolizumab for unresectable melanoma is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• L19IL2 (L19-IL-2)
• L19IL2/L19TNF
• L19TNF
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Philogen S.p.A. | Conditions: Melanoma Stage III, Melanoma Stage IV | Phase 2 | Status: RECRUITING